Higher plasma lipopolysaccharide concentrations are associated with less favorable phenotype in overweight/obese men

European Journal of Nutrition

Volumn 54, Issue 8, 2015, Pages 1363-1370

  Moreira, Ana Paula Boroni ^a   Alves, Raquel Duarte Moreira ^b   Teixeira, Tatiana Fiche Salles ^b   Macedo, Viviane Silva ^b   de Oliveira, Leandro Licursi ^b   Costa, Neuza Maria Brunoro ^c   Bressan, Josefina ^b   do Carmo Gouveia Peluzio, Maria ^b   Mattes, Richard ^d   de Cássia Gonçalves Alfenas, Rita ^b  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^c FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^d PURDUE UNIVERSITY   (United States)

Author keywords

Abdominal obesity; Homeostasis model assessment; Insulin; Lipopolysaccharide

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; INSULIN; LIPOPOLYSACCHARIDE; CARBOHYDRATE DIET; FAT INTAKE; PROTEIN INTAKE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY FAT DISTRIBUTION; DIETARY INTAKE; ENERGY EXPENDITURE; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PANCREAS ISLET BETA CELL; PHENOTYPE; PHYSICAL ACTIVITY; SAGITTAL ABDOMINAL DIAMETER; ADIPOSE TISSUE; ADMINISTRATION AND DOSAGE; ADOLESCENT; BLOOD; BODY MASS; CALORIC INTAKE; CARBOHYDRATE DIET; CROSS-SECTIONAL STUDY; DIETARY FIBER; ENERGY METABOLISM; FAT INTAKE; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; PROTEIN INTAKE; YOUNG ADULT;

ADIPOSE TISSUE; ADOLESCENT; ADULT; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BLOOD PRESSURE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY FIBER; DIETARY PROTEINS; ENERGY INTAKE; ENERGY METABOLISM; HUMANS; INSULIN; INSULIN RESISTANCE; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; OVERWEIGHT; PHENOTYPE; YOUNG ADULT;

EID: 84947611637     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-014-0817-6     Document Type: Article

References (46)

1. Vázquez-Vela MEF, Torres N, Tovar AR (2008) White adipose tissue as endocrine organ and its role in obesity. Arch Med Res 39:715–728
2. Virtue S, Vidal-Puig A (2008) It’s not how fat you are, it’s what you do with it that counts. PLoS Biol 6:e237
3. Montague CT, O’Rahilly S (2000) The perils of portliness: causes and consequences of visceral adiposity. Diabetes 49:883–888
4. Lupattelli G, De Vuono S, Boni M, Helou R, Raffaele Mannarino M, Rita Roscini A, Alaeddin A, Pirro M, Vaudo G (2013) Insulin resistance and not BMI is the major determinant of early vascular impairment in patients with morbid obesity. J Atheroscler Thromb 20:924–933
5. Ding S, Lund PK (2011) Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr Opin Clin Nutr Metab Care 14:328–333
6. Shanik MH, Xu Y, Skrha J, Dankner R, Zick Y, Roth J (2008) Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care 31:S262–S268
7. Reaven GM (1991) Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease. Am Heart J 121(4 Pt 2):1283–1288
8. Klöting N, Fasshauer M, Dietrich A, Kovacs P, Schön MR, Kern M, Stumvoll M, Blüher M (2010) Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 299:E506–E515
9. Ledoux S, Coupaye M, Essig M, Msika S, Roy C, Queguiner I, Clerici C, Larger E (2010) Traditional anthropometric parameters still predict metabolic disorders in women with severe obesity. Obesity 18:1026–1032
10. Könner AC, Brüning JC (2011) Toll-like receptors: linking inflammation to metabolism. Trends Endocrinol Metab 22:16–23
11. Brook JS, Lee JY, Finch SJ, Balka EB, Brook DW (2013) Physical factors, personal characteristics, and substance use: associations with obesity. Subst Abus 34:273–276
12. Trøseid M, Nestvold TK, Rudi K, Thoresen H, Nielse EW, Lappegard KT (2013) Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: evidence from bariatric surgery. Diabetes Care 36:3627–3632
13. Moreira APB, Teixeira TFS, Ferreira AB, Peluzio MCG, Alfenas RCG (2012) Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 108:801–809
14. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761–1772
15. Muccioli GG, Naslain D, Backhed F, Reigstad CS, Lambert DM, Delzenne NM, Cani PD (2010) The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 6:392
16. Wang L, Li L, Ran X, Long M, Zhang M, Tao Y, Luo X, Wang Y, Jiao Y, Mao X, Ren J (2013) Lipopolysaccharides reduce adipogenesis in 3T3-L1 adipocytes through activation of NF-κB pathway and downregulation of AMPK expression. Cardiovasc Toxicol 13:338–346
17. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS (2006) TLR4 links innate immunity and fatty acid—induced insulin resistance. J Clin Investig 116:3015–3025
18. Mehta NN, McGillicuddy FC, Anderson PD, Hinkle CC, Shah R, Pruscino L, Tabita-Martinez J, Sellers KF, Rickels MR, Reilly MP (2010) Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 59:172–181
19. Liang H, Hussey SE, Sanchez-Avila A, Tantiwong P, Musi N (2013) Effect of lipopolysaccharide on inflammation and insulin action in human muscle. PLoS One 8:e63983
20. Pussinen PJ, Havulinna AS, Lehto M, Sundvall J, Salomaa V (2011) Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 34:392–397
21. Miller MA, McTernan PG, Harte AL, Silva NF, Strazzullo P, Alberti KG, Kumar S, Cappuccio FP (2009) Ethnic and sex differences in circulating endotoxin levels: a novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic population. Atherosclerosis 203:494–502
22. Devaraj S, Dasu MR, Park SH, Jialal I (2009) Increased levels of ligands of toll-like receptors 2 and 4 in type 1 diabetes. Diabetologia 52:1665–1668
23. Creely SJ, McTernan PG, Kusminski CM, Fisher FM, Da Silva NF, Khanolkar M, Evans M, Harte AL, Kumar S (2007) Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292:E740–E747
24. Calori G, Lattuada G, Piemonti L, Garancini MP, Ragogna F, Villa M, Mannino S, Crosignani P, Bosi E, Luzi L, Ruotolo G, Perseghin G (2011) Prevalence, metabolic features, and prognosis of metabolically healthy obese italian individuals: the cremona study. Diabetes Care 34:210–215
25. Vasques ACJ, Rosado LEFPL, Rosado GP, Ribeiro RCL, Franceschini SCC, Geloneze B, Priore SE, Oliveira DR (2009) Habilidade de indicadores antropométricos e de composição corporal em identificar a resistência à insulin. Arq Bras Endocrinol Metab 53:72–79
26. Valdez R, Seidell JC, Ahn YI, Weiss KM (1993) A new index of abdominal adiposity as an indicator of risk for cardiovascular disease. A cross-population study. Int J Obes Relat Metab Disord 17:77–82
27. Kahn HS, Austin H, Williamson DF, Arensberg D (1996) Simple anthropometric indices associated with ischemic heart disease. J Clin Epidemiol 49:1017–1024
28. World Health Organization (2001) Food and nutrition technical report series: human energy requirements. WHO, Joint FAO/WHO/UNU Expert Consultation, Rome
29. Pardini R, Matsudo SMM, Araújo T, Matsudo V, Andrade E, Braggion C, Andrade D, Oliveira L, Figueira Júnior A, Raso V (2001) Validação do questionário internacional de nível de atividade física (IPAQ-versão 6): estudo piloto em adultos jovens brasileiros. Rev Bras Ciên Mov 9:45–51
30. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502
31. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
32. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group (2005) The metabolic syndrome: a new worldwide definition. Lancet 366:1059–1062
33. Item F, Konrad D (2012) Visceral fat and metabolic inflammation: the portal theory revisited. Obes Rev 13:30–39
34. Messier V, Karelis AD, Prud’homme D, Primeau V, Brochu M, Rabasa-Lhoret R (2010) Identifying metabolically healthy but obese individuals in sedentary postmenopausal women. Obesity 18:911–917
35. Lam YY, Mitchell AJ, Holmes AJ, Denyer GS, Gummesson A, Caterson ID, Hunt NH, Storlien LH (2011) Role of the gut in visceral fat inflammation and metabolic disorders. Obesity 19:2113–2120
36. Abbasi F, Blasey C, Reaven GM (2013) Cardiometabolic risk factors and obesity: does it matter whether BMI or waist circumference is the index of obesity? Am J Clin Nutr 98:637–640
37. Clemente-Postigo M, Queipo-Ortuño MI, Murri M, Boto-Ordoñez M, Perez-Martinez P, Andres-Lacueva C, Cardona F, Tinahones FJ (2012) Endotoxin increase after fat overload is related to postprandial hypertriacylglycerolemia in morbidly obese patients. J Lipid Res 53:973–978
38. Cornier M-A, Després J-P, Davis N, Grossniklaus DA, Klein S, Lamarche B, Lopez-Jimenez F, Rao G, St-Onge MP, Towfighi A, Poirier P (2011) Assessing adiposity: a scientific statement from the american heart association. Circulation 124:1996–2019
39. Despres J-P, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444:881–887
40. Yu R, Kim CS, Kwon BS, Kawada T (2006) Mesenteric adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue macrophage migration and activation in obese mice. Obesity 14:1353–1362
41. Lee RP, Lin NT, Chao YF, Linn CC, Harn HJ, Chen HI (2007) High-density lipoprotein prevents organ damage in endotoxemia. Res Nurs Health 30:250–260
42. Manco M, Putignani L, Bottazzo GF (2010) Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 31:817–844
43. Tuin A, Huizinga-Van der Vlag A, van Loenen-Weemaes AM, Meijer DK, Poelstra K (2006) On the role and fate of LPS-dephosphorylating activity in the rat liver. Am J Physiol Gastrointest Liver Physiol 290:G377–G385
44. Coimbra R, Porcides RD, Melbostad H, Loomis W, Tobar M, Hoyt DB, Wolf P (2005) Nonspecific phosphodiesterase inhibition attenuates liver injury in acute endotoxemia. Surg Infect 6:73–85
45. Bates JM, Akerlund J, Mittge E, Guillemin K (2007) Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in response to the gut microbiota. Cell Host Microbe 2:371–382
46. Schromm AB, Brandenburg K, Loppnow H, Zähringer U, Rietschel ET, Carroll SF, Koch MHJ, Kusumoto S, Seydel U (1998) The charge of endotoxin molecules influences their conformation and IL-6-inducing capacity. J Immunol 161:5464–5471